Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01876758
Other study ID # #6599
Secondary ID
Status Completed
Phase N/A
First received June 3, 2013
Last updated July 13, 2017
Start date September 2012
Est. completion date May 2017

Study information

Verified date July 2017
Source New York State Psychiatric Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Although electroconvulsive therapy (ECT) remains the most effective treatment for people with severe depression, patients may experience a significant degree of persistent and/or permanent memory problems following ECT. Many patients report the memory problems are the most disturbing and serious side effect of ECT, and that such effects impact their quality of life following treatment and their willingness to consent to further ECT needed to complete a treatment course or to maintain remission. New developments in the field of cognitive remediation have demonstrated the benefits of cognitive training to improve memory performance in various conditions, such as epilepsy. However, these strategies have never been applied to help patients regain memory after ECT. The investigators have designed and piloted a novel cognitive program specifically targeted to the cognitive effects of ECT, based upon a program tailored to people with seizure disorders, a group with memory problems very similar to people who undergo ECT. This Memory Training for ECT (Mem-ECT) is designed to help cognitive functions that may be compromised following ECT remain relatively preserved. In addition, the intervention attempts to help ECT patients quickly regain their general memory skills immediately following ECT. Recent results from our preliminary group of patients who underwent ECT and memory training at New York Presbyterian shows no overall decline in memory function following ECT. On the basis of these promising findings, the investigators propose a more rigorous and larger study to confirm whether this novel memory training program can help alleviate memory problems associated with ECT.


Description:

The investigators propose to enroll 60 patients scheduled to undergo ECT over the course of 3 years. They will be randomly assigned to one of three research conditions (a) participants in Mem-ECT condition will receive memory training before and after their ECT course, (b) participants in the active control condition will work on commercially available puzzle games at the same times prior and after ECT to determine if the developed memory training program is more effective than mere mental stimulation, (c) participants in the "treatment as usual" will not work on the memory training or the puzzle games but just undergo the study evaluations. Participants will be evaluated a few days before ECT, within 2 weeks following ECT, and once again 2 months later. The evaluation will consist of interviews, mental skill testing, and measuring brain waves using an electroencephalograph (EEG) before ECT and 2 months after ECT (no EEG right after ECT). It is our hope that developing a safe and effective strategy to minimize the adverse memory side effects of ECT will make ECT a better and more easily tolerated treatment for patients with severe depression who need this therapeutic option.


Recruitment information / eligibility

Status Completed
Enrollment 59
Est. completion date May 2017
Est. primary completion date August 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Diagnosis of Major Depressive Disorder

- Inpatient at NYSPI or Presbyterian Hospital

- Scheduled to undergo right-unilateral electroconvulsive therapy in the next two weeks

- We do not require participants to be psychiatrically stable in terms of their symptoms. They only need to demonstrate capacity to consent and be willing to sit through 3 training sessions prior to ECT and 5 sessions post ECT

Exclusion Criteria:

- Significant auditory/visual impairment that would interfere with study procedures

- Lack of aptitude in English that may interfere with the administration of the tests

- Changes in the type of antidepressant during the course of ECT or 2 weeks post ECT

- Chart diagnosis of any other medical or neuropsychiatric illnesses known to impair brain function (e.g. mental retardation, traumatic brain injury, schizophrenia)

- History of ECT in past 2 months

- Mental status examination score below 40/57

- Current substance abuse (e.g. marijuana or crack), excluding nicotine and caffeine.

- Too agitated to sit through the required tests or training

Study Design


Intervention

Behavioral:
Cognitive Intervention: Memory Training
Paper-and-pencil and computerized exercises pre- and post-ECT which may be helpful in recovering episodic memories and allow for the retention of learned strategies
Comparable general mental stimulation
Active control will work on commercially available puzzle games at the same time prior and after ECT to determine if the developed memory training program is more effective than mere mental stimulation.

Locations

Country Name City State
United States New York State Psychiatric Institute New York New York

Sponsors (1)

Lead Sponsor Collaborator
New York State Psychiatric Institute

Country where clinical trial is conducted

United States, 

References & Publications (1)

Choi J, Lisanby SH, Medalia A, Prudic J. A conceptual introduction to cognitive remediation for memory deficits associated with right unilateral electroconvulsive therapy. J ECT. 2011 Dec;27(4):286-91. doi: 10.1097/YCT.0b013e31821d3ab3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Modified Mini-Mental State examination 2 months after the last ECT session
Primary Columbia University Autobiographical Memory Interview-Short Form (AMI-SF) 2 months after the last ECT session
Secondary Goldberg Remote Memory Questionnaire 2 months after the last ECT session
Secondary Hamilton Rating Scale for Depression-24 item 2 months after the last ECT session
See also
  Status Clinical Trial Phase
Completed NCT04348825 - Electroconvulsive Therapy and Neuroradiology
Enrolling by invitation NCT05515159 - Blood Biomarkers in Electroconvulsive Therapy
Completed NCT04022226 - EEG Characteristics in ECT Early Phase 1
Recruiting NCT05889234 - Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort Study
Recruiting NCT04291196 - Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT N/A
Recruiting NCT04160286 - The Danish Neuropsychological Study of the Adverse Effects of ECT
Terminated NCT04383509 - Electroconvulsive Treatment Followed by Cognitive Control Training N/A
Completed NCT05683028 - RCT for Electroconvulsive Treatment Followed by Cognitive Control Training N/A
Completed NCT05633368 - Impact of Covid-19 Pandemic on Patients Receiving Continuation or Maintenance Electroconvulsive Therapy
Completed NCT03359395 - Pre-medication With Alfentanil vs Placebo During ECT Phase 4
Recruiting NCT05900245 - Anesthesia Induction Schemes of Electroconvulsive Convulsions in Patients With Depression Based on EEG Monitoring N/A
Recruiting NCT03542903 - ECT in Ultra-resistant Schizophrenia N/A
Completed NCT02819375 - Comparison of Propofol, Propofol-remifentanil and Propofol-ketamine Anesthesia During Electroconvulsive Therapy Phase 4
Not yet recruiting NCT02305394 - Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy Phase 4
Completed NCT02394847 - Does Repetitive Electroconvulsive Therapies Affect Propofol Induction Dose ? N/A
Recruiting NCT06109480 - Effect of HD-tDCS Assisted ECT for Depression Disorder N/A
Completed NCT05408000 - Comparision of Motor Seizure Duration of Ketofol and Propofol for Electroconvulsive Therapy N/A
Completed NCT01870219 - Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy Phase 4
Completed NCT04028596 - Measuring Blood Flow in the Brain After Epileptic Activity Phase 2
Completed NCT03113968 - ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) Phase 2/Phase 3